Hepatitis Web Study

References

  1. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus. Hepatology. 1983;3:656-62.
    [The following link will open in a new window. PubMed Abstract]
  2. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis. 1997;175:1285-93.
    [The following link will open in a new window. PubMed Abstract]
  3. Chu CJ, Keeffe EB, Han SH, et al. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology. 2003;125:444-51.
    [The following link will open in a new window. PubMed Abstract]
  4. Chu CJ, Keeffe EB, Han SH, et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology. 2003;38:619-28.
    [The following link will open in a new window. PubMed Abstract]
  5. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B Virus e Antigen Variants. Int J Med Sci. 2005;2:2-7.
    [The following link will open in a new window. PubMed Abstract]
  6. Schlicht HJ, Schaller H. The secretory core protein of human hepatitis B virus is expressed on the cell surface.J Virol. 1989;63:5399-404.
    [The following link will open in a new window. PubMed Abstract]
  7. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology. 2004;39:857-61.
    [The following link will open in a new window. PubMed Abstract]
  8. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;2:588-91.
    [The following link will open in a new window. PubMed Abstract]
  9. Okamoto H, Tsuda F, Akahane Y, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68:8102-10.
    [The following link will open in a new window. PubMed Abstract]
  10. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res. 2001;52:91-8.
    [The following link will open in a new window. PubMed Abstract]
  11. Ballard AL, Boxall EH. Epidemiology of precore mutants of hepatitis B in the United Kingdom. J Med Virol. 2000;62:463-70
    [The following link will open in a new window. PubMed Abstract]
  12. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 2001;34(4 Pt 1):617-24.
    [The following link will open in a new window. PubMed Abstract]
  13. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology. 2002;36:1408-15.
    [The following link will open in a new window. PubMed Abstract]
  14. Yuan HJ, Yuen MF, Ka-Ho Wong D, Sum SM, Sablon E, Oi-Lin Ng I, Lai CL. Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2005;22:301-7.
    [The following link will open in a new window. PubMed Abstract]
  15. Brunetto MR, Giarin MM, Oliveri F, et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A. 1991;88:4186-90.
    [The following link will open in a new window. PubMed Abstract]
  16. Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.Clin Gastroenterol Hepatol. 2004;2(2):87-106.
    [The following link will open in a new window. PubMed Abstract]

[Back to Question | Back to Discussion]

CME Credit | CNE Credit | Back to Top